(AEYE) AudioEye - Overview
Stock: Accessibility Software, Monitoring Services, PDF Remediation, Audit Reporting
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 80.0% |
| Relative Tail Risk | -9.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.18 |
| Alpha | -87.57 |
| Character TTM | |
|---|---|
| Beta | 1.901 |
| Beta Downside | 1.866 |
| Drawdowns 3y | |
|---|---|
| Max DD | 77.50% |
| CAGR/Max DD | 0.10 |
Description: AEYE AudioEye January 18, 2026
AudioEye, Inc. (NASDAQ:AEYE) delivers SaaS-based accessibility solutions that automatically convert web and digital content into formats compliant with the Web Content Accessibility Guidelines (WCAG). Its platform provides continuous testing, AI-driven remediation, 24/7 monitoring, and supplemental services such as PDF remediation, mobile app accessibility, legal support, and audit reporting for a broad client base that includes SMBs, enterprises, nonprofits, and government agencies across the U.S. and Europe.
Key market drivers include tightening accessibility regulations (e.g., the U.S. ADA and the EU’s Web Accessibility Directive) and a growing corporate focus on inclusive digital experiences, which together underpin an estimated $12 billion global accessibility software market by 2027. In FY 2023, AudioEye reported $31 million in revenue, a 28 % year-over-year increase, and an ARR-based gross margin of roughly 80 %, reflecting the high-margin nature of subscription SaaS. The company’s churn rate has remained below 5 % annually, indicating strong customer retention in a sector where compliance risk drives sticky contracts.
For a deeper dive into how AudioEye’s valuation compares to peers and the broader accessibility trend, you might find ValueRay’s analytical tools useful.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -3.51m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -2.48 > 1.0 |
| NWC/Revenue: -0.13% < 20% (prev -6.64%; Δ 6.51% < -1%) |
| CFO/TA 0.09 > 3% & CFO 2.79m > Net Income -3.51m |
| Net Debt (8.68m) to EBITDA (899.0k): 9.65 < 3 |
| Current Ratio: 1.00 > 1.5 & < 3 |
| Outstanding Shares: last quarter (12.4m) vs 12m ago 3.80% < -2% |
| Gross Margin: 78.61% > 18% (prev 0.79%; Δ 7782 % > 0.5%) |
| Asset Turnover: 132.1% > 50% (prev 113.5%; Δ 18.62% > 0%) |
| Interest Coverage Ratio: -2.79 > 6 (EBITDA TTM 899.0k / Interest Expense TTM 926.0k) |
Altman Z'' -15.00
| A: -0.00 (Total Current Assets 11.8m - Total Current Liabilities 11.9m) / Total Assets 30.5m |
| B: -3.33 (Retained Earnings -101.4m / Total Assets 30.5m) |
| C: -0.09 (EBIT TTM -2.59m / Avg Total Assets 29.9m) |
| D: -4.08 (Book Value of Equity -101.4m / Total Liabilities 24.8m) |
| Altman-Z'' Score: -15.72 = D |
Beneish M -3.01
| DSRI: 1.10 (Receivables 6.34m/4.88m, Revenue 39.5m/33.3m) |
| GMI: 1.00 (GM 78.61% / 78.87%) |
| AQI: 1.02 (AQ_t 0.60 / AQ_t-1 0.59) |
| SGI: 1.19 (Revenue 39.5m / 33.3m) |
| TATA: -0.21 (NI -3.51m - CFO 2.79m) / TA 30.5m) |
| Beneish M-Score: -3.01 (Cap -4..+1) = AA |
What is the price of AEYE shares?
Over the past week, the price has changed by -17.20%, over one month by -20.16%, over three months by -42.14% and over the past year by -59.90%.
Is AEYE a buy, sell or hold?
- StrongBuy: 2
- Buy: 3
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AEYE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 21.4 | 174.4% |
| Analysts Target Price | 21.4 | 174.4% |
| ValueRay Target Price | 7.7 | -1.3% |
AEYE Fundamental Data Overview February 04, 2026
P/S = 2.8455
P/B = 20.7453
P/EG = 2.3727
Revenue TTM = 39.5m USD
EBIT TTM = -2.59m USD
EBITDA TTM = 899.0k USD
Long Term Debt = 12.6m USD (from longTermDebt, last quarter)
Short Term Debt = 548.0k USD (from shortTermDebt, last quarter)
Debt = 13.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.68m USD (from netDebt column, last quarter)
Enterprise Value = 121.2m USD (112.5m + Debt 13.2m - CCE 4.55m)
Interest Coverage Ratio = -2.79 (Ebit TTM -2.59m / Interest Expense TTM 926.0k)
EV/FCF = 52.21x (Enterprise Value 121.2m / FCF TTM 2.32m)
FCF Yield = 1.92% (FCF TTM 2.32m / Enterprise Value 121.2m)
FCF Margin = 5.87% (FCF TTM 2.32m / Revenue TTM 39.5m)
Net Margin = -8.88% (Net Income TTM -3.51m / Revenue TTM 39.5m)
Gross Margin = 78.61% ((Revenue TTM 39.5m - Cost of Revenue TTM 8.46m) / Revenue TTM)
Gross Margin QoQ = 77.39% (prev 77.30%)
Tobins Q-Ratio = 3.98 (Enterprise Value 121.2m / Total Assets 30.5m)
Interest Expense / Debt = 1.78% (Interest Expense 236.0k / Debt 13.2m)
Taxrate = 21.0% (US default 21%)
NOPAT = -2.04m (EBIT -2.59m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.00 (Total Current Assets 11.8m / Total Current Liabilities 11.9m)
Debt / Equity = 2.34 (Debt 13.2m / totalStockholderEquity, last quarter 5.65m)
Debt / EBITDA = 9.65 (Net Debt 8.68m / EBITDA 899.0k)
Debt / FCF = 3.74 (Net Debt 8.68m / FCF TTM 2.32m)
Total Stockholder Equity = 7.60m (last 4 quarters mean from totalStockholderEquity)
RoA = -11.74% (Net Income -3.51m / Total Assets 30.5m)
RoE = -46.25% (Net Income TTM -3.51m / Total Stockholder Equity 7.60m)
RoCE = -12.80% (EBIT -2.59m / Capital Employed (Equity 7.60m + L.T.Debt 12.6m))
RoIC = -10.96% (negative operating profit) (NOPAT -2.04m / Invested Capital 18.7m)
WACC = 11.71% (E(112.5m)/V(125.7m) * Re(12.92%) + D(13.2m)/V(125.7m) * Rd(1.78%) * (1-Tc(0.21)))
Discount Rate = 12.92% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.84%
[DCF Debug] Terminal Value 55.57% ; FCFF base≈2.58m ; Y1≈1.69m ; Y5≈772.6k
Fair Price DCF = 0.05 (EV 9.33m - Net Debt 8.68m = Equity 658.8k / Shares 12.4m; r=11.71% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 88.84 | EPS CAGR: 125.2% | SUE: -4.0 | # QB: 0
Revenue Correlation: 95.65 | Revenue CAGR: 12.88% | SUE: -0.78 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.19 | Chg30d=-0.005 | Revisions Net=-1 | Analysts=4
EPS next Year (2026-12-31): EPS=0.84 | Chg30d=-0.012 | Revisions Net=-1 | Growth EPS=+19.6% | Growth Revenue=+10.8%